|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:16,536,140...61,536,140
|
|
Q |
Emca11 |
Estrogen-induced mammary cancer QTL 11 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:99,753,548...113,061,097
|
|
Q |
Emca12 |
Estrogen-induced mammary cancer QTL 12 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:124,160,767...133,749,643
|
|
Q |
Emca13 |
Estrogen-induced mammary cancer QTL 13 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:9,823,266...99,753,708
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:12,789,751...113,558,310
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:7,887,772...12,654,247
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:32,373,770...43,665,178
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:16,491,740...61,491,740
|
|
Q |
Mamtr5 |
Mammary tumor resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:23,671,493...68,671,493
|
|
Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,278,901...83,218,561
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q |
Mcs1 |
Mammary carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:9,623,581...25,054,526
|
|
Q |
Mcs12 |
Mammary carcinoma susceptibility QTL 12 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:58,973,449...60,051,321
|
|
Q |
Mcs13 |
Mammary carcinoma susceptibility QTL 13 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:63,190,890...69,927,503
|
|
Q |
Mcs14 |
Mammary carcinoma susceptibility QTL 14 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:76,369,776...80,813,390
|
|
Q |
Mcs15 |
Mammary carcinoma susceptibility QTL 15 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:85,565,469...103,884,409
|
|
Q |
Mcs16 |
Mammary carcinoma susceptibility QTL 16 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 1:1...26,564,886
|
|
Q |
Mcs17 |
Mammary carcinoma susceptibility QTL 17 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 1:207,099,883...252,099,883
|
|
Q |
Mcs18 |
Mammary carcinoma susceptibility QTL 18 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 2:9,623,581...44,538,110
|
|
Q |
Mcs19 |
Mammary carcinoma susceptibility QTL 19 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 5:82,032,155...127,032,155
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:20,920,494...37,412,865
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 9:21,031,430...49,025,574
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:29,377,046...52,699,134
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
|
|
Q |
Mcs23 |
Mammary carcinoma susceptibility QTL 23 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q |
Mcs24 |
Mammary carcinoma susceptibility QTL 24 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:69,835,120...114,835,120
|
|
Q |
Mcs25 |
Mammary carcinoma susceptibility QTL 25 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:10,894,415...110,548,006
|
|
Q |
Mcs26 |
Mammary carcinoma susceptibility QTL 26 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:106,752,656...132,339,866
|
|
Q |
Mcs27 |
Mammary carcinoma susceptibility QTL 27 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:43,437,904...47,841,255
|
|
Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,743,239...78,039,084
|
|
Q |
Mcs29 |
Mammary carcinoma susceptibility QTL 29 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,816,155...77,988,860
|
|
Q |
Mcs3 |
Mammary carcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:111,404,407...142,582,336
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:5,633,306...50,633,306
|
|
Q |
Mcs31 |
Mammary carcinoma susceptibility QTL 31 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:85,262,459...118,999,486
|
|
Q |
Mcs32 |
Mammary carcinoma susceptibility QTL 32 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
Q |
Mcs33 |
Mammary carcinoma susceptibility QTL 33 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:136,631,198...172,190,305
|
|
Q |
Mcs34 |
Mammary carcinoma susceptibility QTL 34 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr18:65,635,567...85,897,775
|
|
Q |
Mcs4 |
Mammary carcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:44,475,043...89,475,043
|
|
Q |
Mcs5 |
Mammary carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:60,601,597...137,492,949
|
|
Q |
Mcs6 |
Mammary carcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:28,624,575...65,788,017
|
|
Q |
Mcs7 |
Mammary carcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,724,423...107,713,808
|
|
Q |
Mcs8 |
Mammary carcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,957,878...24,886,169
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:64,367,996...109,367,996
|
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IDA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:6,922,282...81,330,203
|
|
Q |
Eutr2 |
Estrogen induced uterine response QTL 2 |
|
IDA |
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:34,730,116...104,251,008
|
|
|
Q |
Edcs1 |
Endometrial carcinoma susceptibility QTL1 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr11:18,976,208...24,697,116
|
|
Q |
Edcs2 |
Endometrial carcinoma susceptibility QTL2 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr12:1...11,869,600
|
|
Q |
Edcs3 |
Endometrial carcinoma susceptibility QTL3 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
|
|
Q |
Edcs4 |
Endometrial carcinoma susceptibility QTL 4 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr 1:206,081,677...251,081,677
|
|
Q |
Edcs5 |
Endometrial carcinoma susceptibility QTL 5 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr17:57,246,723...70,852,846
|
|